Atropos Health Collaborates with Merck for Rapid Evidence Generation to Accelerate Innovation for Life-Saving TreatmentsBusiness Wire • 01/10/25
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the marketCNBC • 01/08/25
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and MoreBenzinga • 12/22/24
Want to Collect a Dividend Every Month? Invest in These 3 High-Yielding Income StocksThe Motley Fool • 12/20/24
Merck Closes Exclusive Global License Agreement for LM-299, An Investigational Anti-PD-1/VEGF Bispecific AntibodyBusiness Wire • 12/20/24